SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-122120
Filing Date
2023-04-27
Accepted
2023-04-27 16:05:56
Documents
4
Period of Report
2023-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A d438804ddef14a.htm DEF 14A 863786
2 GRAPHIC g438804g02m95.jpg GRAPHIC 75026
3 GRAPHIC g438804g04p35.jpg GRAPHIC 17842
4 GRAPHIC g438804g04p58.jpg GRAPHIC 97208
  Complete submission text file 0001193125-23-122120.txt   1127193
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38722 | Film No.: 23856801
SIC: 2836 Biological Products, (No Diagnostic Substances)